Sabra Healthcare SBRA Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Net margin | 20.1%+2.1pp | 18%+15.9pp | 2.1%+14.5pp | -12.4%+7.5pp | |
| EBITDA margin | 58.5%-0.3pp | 58.7%+9.2pp | 49.5%+0.3pp | 49.2%— | |
| Returns | |||||
| Return on equity | 5.6%+1.0pp | 4.6%+4.1pp | 0.5%+2.9pp | -2.4%+0.9pp | |
| Return on assets | 2.9%+0.5pp | 2.4%+2.1pp | 0.2%+1.6pp | -1.3%+0.6pp | |
| Return on invested capital | 9.6%+0.8pp | 8.8%+4.6pp | 4.2%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | |
| Net debt / EBITDA | -0.1×0.0× | -0.1×0.0× | -0.1×0.0× | -0.1×— | |
| Interest coverage | 2.4×+0.3× | 2.1×+1.0× | 1.2×-0.1× | 1.2×— | |
| Per Share | |||||
| Book value per share | $11.54-0.6% | $11.61-3.5% | $12.04-9.0% | $13.23-14.2% | |
| Valuation | |||||
| Market capitalization | $4.72B+15.3% | $4.1B+24.2% | $3.3B+14.9% | $2.87B-8.1% | |
| Enterprise value | $4.66B+15.2% | $4.05B+23.7% | $3.27B+15.5% | $2.83B— | |
| Price / earnings | 30.3×-2.0× | 32.3×-208× | 239.9×— | —— | |
| Price / sales | 6.1×+0.3× | 5.8×+0.7× | 5.1×+0.5× | 4.6×-0.9× | |
| Price / book | 1.7×+0.2× | 1.5×+0.3× | 1.2×+0.2× | 0.9×0.0× | |
| EV / EBITDA | 10.3×+0.5× | 9.8×-0.4× | 10.2×+1.0× | 9.2×— | |
| EV / sales | 6×+0.3× | 5.8×+0.7× | 5.1×+0.5× | 4.5×— | |
| Earnings yield | 3.3%+0.2pp | 3.1%+2.7pp | 0.4%+3.1pp | -2.7%+0.9pp | |
| Dividend yield | 6.1%-0.7pp | 6.8%-1.6pp | 8.4%-1.2pp | 9.7%+1.2pp | |
| PEG ratio | 1.3×+1.3× | 0×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Sabra Healthcare's ratios come from?
- Every ratio is computed from Sabra Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.